Product
HEPLISAV B
1 clinical trial
1 indication
Indication
Chronic Hepatitis BClinical trial
TherVacB_Phase1a: Open Phase 1a Trial to Assess the Safety and Immunogenicity of a Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate in Healthy VolunteersStatus: Recruiting, Estimated PCD: 2025-02-01